CARE Ratings

Regulatory Reforms And Global Expansion Will Drive Rating Demand

AnalystConsensusTarget

Not Invested

Consensus Narrative from 1 Analyst

Published

04 Sep 25

AnalystConsensusTarget's Fair Value

₹1,996.00

17.8% undervalued

04 Sep

₹1,641.00

67.9%

3.9%

67.9%

3.9%

Edit anytime before Sep 4 8:12 PM. Then post Updates to your followers.

Author's Valuation

₹2.0k

17.8% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

₹2.0k

17.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

15.14%

Capital Markets revenue growth rate

0.27%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

14.70%

Calculation

₹2.28b

Earnings '28

39.66x

PE Ratio '28

₹90.26b

Market Cap '28

₹90.26b

Market Cap '28

30.03m

No. shares '28

₹3.01k

Share Price '28

₹3.01k Share Price '28

Discounted to 2025 @ 14.66% p.a.

₹1.99k

Fair Value '25